Curis (CRIS) Research & Development (2010 - 2026)
Curis (CRIS) reported Research & Development of $6.4 million for Q1 2026, down 24.48% on a YoY basis from $8.5 million in Q1 2025, and up 10.71% quarter-over-quarter from $5.8 million in Q4 2025.
Curis (CRIS) Research & Development (2010 - 2026) Analysis & Trends
Curis has reported Research & Development for 17 years, with the latest figure at $6.4 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 24.48% year-over-year to $6.4 million; the trailing twelve-month figure through Mar 2026 stood at $26.2 million (down 30.2% YoY), and the FY2025 full-year result was $28.3 million, down 26.73% from the prior year.
- Research & Development for Q1 2026 stood at $6.4 million, up from $5.8 million in the prior quarter.
- The five-year high for Research & Development was $12.3 million in Q2 2022, with the low at $5.8 million in Q4 2025.
- Historically, Research & Development has averaged $9.2 million across 5 years, with a median of $9.6 million in 2024.
- Annual changes were most pronounced in 2022 — Research & Development surged 69.23% — and 2025, when it tumbled 35.05%.
- Curis' Research & Development stood at $8.7 million in 2022, then rose by 14.45% to $10.0 million in 2023, then slipped by 10.0% to $9.0 million in 2024, then plunged by 35.05% to $5.8 million in 2025, then rose by 10.71% to $6.4 million in 2026.
- The last three Research & Development figures came in at $6.4 million (Q1 2026), $5.8 million (Q4 2025), and $6.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -58.00 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | 6.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.45 Mn |
| Dec 31, 2025 | 5.83 Mn |
| Sep 30, 2025 | 6.43 Mn |
| Jun 30, 2025 | 7.46 Mn |
| Mar 31, 2025 | 8.54 Mn |
| Dec 31, 2024 | 8.97 Mn |
| Sep 30, 2024 | 9.72 Mn |
| Jun 30, 2024 | 10.25 Mn |
| Mar 31, 2024 | 9.62 Mn |
| Dec 31, 2023 | 9.96 Mn |
| Sep 30, 2023 | 10.38 Mn |
| Jun 30, 2023 | 10.01 Mn |
| Mar 31, 2023 | 9.14 Mn |
| Dec 31, 2022 | 8.71 Mn |
| Sep 30, 2022 | 10.81 Mn |
| Jun 30, 2022 | 12.32 Mn |
| Mar 31, 2022 | 11.44 Mn |
| Dec 31, 2021 | 10.77 Mn |
| Sep 30, 2021 | 8.60 Mn |
| Jun 30, 2021 | 8.75 Mn |